Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide.
Oncotarget
; 14: 837-838, 2023 Sep 25.
Article
in En
| MEDLINE
| ID: mdl-37747363
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Oncotarget
Year:
2023
Type:
Article
Affiliation country:
United States